Overview: Total Cholesterol (Chol Total) TestIntroduction: The Total Cholesterol Test measures total cholesterol to assess heart disease risk, causing chest pain or shortness of breath. Following 2023 AHA guidelines, it uses spectrophotometry for high sensitivity, aiding in cardiovascular screening. This test is critical for guiding risk assessment, preventive strategies, and improving outcomes in biochemistry for patients with suspected cardiovascular conditions.
Other Names: Cholesterol Assay, Lipid Profile Test.
FDA Status: Laboratory-developed test (LDT), meeting biochemistry standards for diagnostic accuracy.
Historical Milestone: Cholesterol testing began in the 1950s with cardiovascular research. Spectrophotometry emerged in the 1970s, and by the 2000s, automated analyzers improved accuracy.
Purpose: Assesses heart disease risk, guides preventive measures, and monitors cholesterol levels in patients with chest pain or shortness of breath.
Test Parameters: 1. Total Cholesterol
Pretest Condition: Fasting for 10-12 hours required to stabilize cholesterol levels. Collect serum or plasma after overnight fasting. Report symptoms like chest pain or shortness of breath, and list medications like statins.
Specimen: 2-5 mL serum (SST) or 2-4 mL plasma (EDTA). Centrifuge within 1 hour. Transport in a biohazard bag within 8 hours.
Sample Stability at Room Temperature: 8 hours
Sample Stability at Refrigeration: 7 days
Sample Stability at Frozen: 6 months
Medical History: Document cardiovascular symptoms, family history of heart disease, or lipid disorders. Include current medications, especially statins or fibrates.
Consent: Written consent required, detailing the tests purpose, implications for heart disease risk, and potential need for lipid-lowering therapy.
Procedural Considerations: Uses spectrophotometry to measure total cholesterol levels. Results are available in 1-2 days, enabling rapid clinical decisions.
Factors Affecting Result Accuracy: Non-fasting samples or lipid-lowering medications may alter results. Hemolysis or improper storage can degrade samples.
Clinical Significance: Elevated cholesterol levels indicate increased heart disease risk, prompting lifestyle changes or statin therapy. Normal levels support ongoing monitoring.
Specialist Consultation: Consult a cardiologist for result interpretation. A lipidologist referral is advised for complex dyslipidemia cases.
Additional Supporting Tests: Lipid profile, Apo B test, or hs-CRP to assess cardiovascular risk comprehensively.
Test Limitations: Results may not fully predict heart disease risk without clinical correlation. Integration with other lipid markers is required.
References: AHA Lipid Guidelines, 2023; Circulation, Grundy SM, 2022.
